RADiant provides surface radiation therapy treatment for a wide range of superficial skin conditions, including basal and squamous cell carcinoma. RADiant is the first dual-modality system designed for dermatologists to offer both electronic brachytherapy and superficial radiation therapy. In this webinar, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, describes these modalities, patient selection criteria, and outcomes. Dr. Davis has performed more than 25,000 skin cancer operations and chose Xstrahl’s RADiant system to expand his practice.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
